The role of combination therapy in the treatment of hypertension

American Journal of Hypertension

Volumn 11, Issue 6 II SUPPL., 1998, Pages

  Moser, Marvin ^a,c   Black, Henry R ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

Combination therapy; Hypertension; Treatment

Indexed keywords

AMLODIPINE PLUS BENAZEPRIL; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BISOPROLOL FUMARATE PLUS HYDROCHLOROTHIAZIDE; CALCIUM ANTAGONIST; CAPTOPRIL; CAPTOPRIL PLUS HYDROCHLOROTHIAZIDE; CLONIDINE; DILTIAZEM; DILTIAZEM PLUS ENALAPRIL MALEATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL MALEATE PLUS FELODIPINE; FELODIPINE; HYDRALAZINE; HYDRALAZINE PLUS HYDROCHLOROTHIAZIDE PLUS RESERPINE; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS LOSARTAN; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; LOSARTAN; PRAZOSIN; RESERPINE; TRANDOLAPRIL PLUS VERAPAMIL; TRIAMTERENE; UNCLASSIFIED DRUG;

ANTIHYPERTENSIVE THERAPY; CLINICAL PROTOCOL; COMBINATION CHEMOTHERAPY; DRUG COST; DRUG EFFECT; DRUG INDICATION; HYPERTENSION; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 0031817770     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(98)00060-0     Document Type: Review

References (20)

1. Heart Facts. American Heart Association 70th Scientific Session, Orlando, Florida, November 1997.
2. Hebert P, Moser M, Mayer J, Hennekens CH: Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med 1993;153:578-581.
3. Joint National Committee: Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997; 157:2413-2446.
4. Staessen JA, Fagard R, Thijs L, et al, for the Systolic Hypertension Europe (Syst-Eur) Trial Investigators: Morbidity and mortality in the placebo-controlled European Trial on Isolated Systolic Hypertension in the Elderly. Lancet 1997;350:757-764.
5. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-3264.
6. Joint National Committee: Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993; 153:154-183.
7. Joint National Committee: Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1984;144:1045-1057.
8. Joint National Committee: Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1988;148:1023-1038.
9. Jones JK, Gorkin L, Lian JF, et al: Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. Br Med J 1995;311:293-295.
10. Materson BJ, Reda DJ, Cushman CW, for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents: Department of Veterans Affairs Single-Drug Therapy of Hypertension Study. Am J Hypertens 1995;8:189-192.
11. Materson BJ, Reda DJ, Cushman WC, Henderson WG, for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents: Results of combination antihypertensive therapy after failure of each of the components. J Human Hypertens 1995;9: 791-796.
12. Black HR: Fixed-dose combination therapy for hypertension. Patient Care 1997;May:13-20.
13. Moser M, Prisant LM: Low-dose combination therapy in hypertension. Am Family Physician 1997;56:1275-1282.
14. Frishman WH, Bryzinski BS, Coulson LR, et al: A multifactorial design to assess combination therapy in hypertension: treatment with bisoprolol and hydrochlorothiazide. Arch Intern Med 1994;154:1461-1468.
15. Prisant LM, Weir MR, Papademetriou V, et al: Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment. Am Heart J 1995; 130:359-366.
16. Gradman AH, Cutler NR, Davis PJ, et al: Combined enalapril and felodipine extended release (ER) for systemic hypertension. Am J Cardiol 1997;79:431-435.
17. MacKay JH, Arcuri KE, Goldberg AL, et al: Losartan and low-dose hydrochlorothiazide in patients with essential hypertension: a double-blind, placebo-controlled trial of concomitant administration compared with individual components. Arch Intern Med 1996; 156:278-285.
18. Epstein M, Bakris G: Newer approaches to antihypertensive therapy: use of fixed-dose combination therapy. Arch Intern Med 1994;154:1461-1468.
19. Sica DA: Fixed-dose combination antihypertensive drugs: do they have a role in rational therapy? Drugs 1994;48:16-24.
20. Burt VL, Cutler JA, Higgins M, et al: Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Hypertens 1995; 26:60-69.